Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target
Gilead Sciences’ inflammation drug prospects have come via deals, and the latest one brings drug candidates for an elusive target ...
Tag: Pact
GSK, Flagship Pioneering Commit $150M to Start R&D Pact for Novel Drugs and Vaccines
GSK already has a strong presence in respiratory disease and immunology, two of its core therapeutic areas. The pharmaceutical giant ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!